跳至主要内容
临床试验/NCT00390039
NCT00390039已完成3 期

Randomized, Double-Blind, Active- and Placebo-Controlled Study of Analgesic Efficacy and Safety of Repeated Dosing of MNS075 (Intranasal Morphine), IV Morphine, and Placebo in Acute Post-Operative Pain After Elective Orthopedic Surgery

Javelin Pharmaceuticals6 个研究点 分布在 1 个国家目标入组 256 人开始时间: 2006年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
256
试验地点
6
主要终点
Sum of the Pain Intensity Differences (SPID) over 0-24 hours based on Visual Analog Scale (VAS)

研究概览

简要总结

Multiple-center, multiple-dose, randomized, double-blind, six-arm, active- and placebo-controlled study in patients with moderate to severe post-surgical pain from elective orthopedic surgery with safety observed for a total of 30 hours post first dose.

详细描述

Multiple-center, multiple-dose, randomized, double-blind, six-arm, active- and placebo-controlled study of repeated intermittent PRN dosing for 24 hours of Intranasal (IN) Morphine Nasal Spray (MNS075) 7.5 mg and 15 mg, 7.5 mg IV morphine infusions and placebo (either IN or IV), in patients with moderate to severe post-surgical pain from elective orthopedic surgery with safety observed for a total of 30 hours post first dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Over 18 years old
  • Scheduled (within two weeks of the screening visit) to undergo elective orthopedic surgery (e.g., bunionectomy, arthroscopic knee surgery, rotator cuff repair)
  • Moderate to severe pain within 8 hours following completion of the required surgery

排除标准

  • Previous anaphylactic or serious allergic reaction to shellfish or opioids
  • History of sleep apnea
  • Other Inclusion/Exclusion Criteria May Apply

研究组 & 干预措施

A

Experimental

MNS075 7.5mg

干预措施: Intranasal morphine (Drug)

B

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

C

Active Comparator

IV Morphine

干预措施: IV morphine (Drug)

E

Experimental

MNS075 15mg

干预措施: Intranasal morphine (Drug)

D

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

F

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Sum of the Pain Intensity Differences (SPID) over 0-24 hours based on Visual Analog Scale (VAS)

时间窗: Multiple

次要结局

  • Other measures of pain(Multiple)

研究者

发起方
Javelin Pharmaceuticals
申办方类型
Industry

研究点 (6)

Loading locations...

相似试验